세계의 헬스케어용 군유전체학 시장 보고서(2025년)

Metagenomics in healthcare is the analysis of genetic material obtained directly from clinical or environmental samples to study entire microbial communities without the need for culturing. It aids in identifying pathogens, examining microbiome composition, and detecting disease-associated microbial changes, enabling accurate diagnosis, personalized therapy, and enhanced infection management.

The main types of metagenomics in healthcare are sample extraction kits and metagenomics kits. Sample extraction kits are commercially available tools designed to efficiently and reliably isolate deoxyribonucleic acid or ribonucleic acid from biological samples. It employs technologies such as next-generation sequencing, polymerase chain reaction, and microarray, and follows workflows including sample collection, deoxyribonucleic acid extraction, library preparation, and sequencing. It is applied in infectious disease diagnosis, genomic epidemiology, personalized medicine, microbiome analysis, and drug discovery, serving end users including hospitals, diagnostic laboratories, research institutes, pharmaceutical companies, and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The metagenomics in healthcare market research report is one of a series of new reports from The Business Research Company that provides metagenomics in healthcare market statistics, including metagenomics in the healthcare industry's global market size, regional shares, competitors with a metagenomics in healthcare market share, detailed metagenomics in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics in healthcare industry. This metagenomics in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to rising adoption of bioinformatics tools to analyze complex metagenomic data, increasing need for rapid and accurate pathogen detection methods, and growing use of metagenomics in drug discovery and biomarker identification.

The metagenomics in healthcare market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to increasing prevalence of infectious diseases, rising demand for precision medicine, greater focus on antimicrobial resistance surveillance using metagenomics, expanding applications of metagenomics in oncology research and diagnostics, and growing awareness of microbiome-based therapies and interventions. Major trends in the forecast period include technological advancements in sequencing platforms, innovations in bioinformatics pipelines, developments in single-cell metagenomics, research and development in microbiome therapeutics, and integration of artificial intelligence in data analysis.

The increasing prevalence of infectious diseases is expected to drive the growth of the metagenomics in healthcare market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The rise in infectious disease prevalence is largely due to increased travel, which accelerates the spread of pathogens across regions and countries. Metagenomics in healthcare plays a crucial role in combating these diseases by enabling the rapid and accurate identification of pathogens, making it essential for managing infectious outbreaks. It reduces diagnostic uncertainty by analyzing complex microbial communities, improving patient outcomes, and facilitating targeted treatment approaches. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose by 10.7% in 2023, reaching 4,850 cases compared to 4,380 in 2022. Consequently, the growing prevalence of infectious diseases is driving the expansion of the metagenomics in healthcare market.

Leading companies in the metagenomics in healthcare market are developing innovative solutions, such as microbial community profiling. This method involves the comprehensive analysis of microbial populations in a specific sample, using sequencing and bioinformatics tools to assess their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a biotechnology company based in China, launched a Human Microbiome Metagenomics Sequencing Package. This package offers an automated, end-to-end workflow for microbial community profiling, making it easier to analyze human microbiome diversity and its link to various diseases. The package reduces manual labor, enhances reproducibility, and lowers costs, making large-scale and clinical microbiome research more accessible. Researchers benefit from faster and more precise microbial identification, as well as adaptable throughput, which aids in biomarker discovery and advances translational health research.

In May 2025, Mapmygenome India Limited, a genomics and diagnostics company based in India, acquired Microbiome Insights Inc. to expand its microbiome sequencing and analysis capabilities. With this acquisition, Mapmygenome aims to strengthen its presence in the North American market and enhance its offerings in personalized health, genomics, and research services. Microbiome Insights Inc., based in Canada, specializes in metagenomics for healthcare applications.

Major players in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc.

North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metagenomics in healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metagenomics in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metagenomics in healthcare market consists of revenues earned by entities by providing services such as bioinformatics analysis, microbial diagnostics, and drug discovery support. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomics in the healthcare market also includes sales of sequencing platforms, reagents, consumables, and bioinformatics tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metagenomics In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metagenomics in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metagenomics in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metagenomics in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: Sample Extraction Kits; Metagenomics Kits
• 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray
• 3) By Workflow: Sample Collection; Deoxyribonucleic Acid Extraction; Library Preparation; Sequencing
• 4) By Application: Infectious Disease Diagnosis; Genomic Epidemiology; Personalized Medicine; Microbiome Analysis; Drug Discovery
• 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Biotechnology Companies
• Subsegments:
• 1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits; Ribonucleic Acid Extraction Kits; Protein Extraction Kits
• 2) By Metagenomics Kits: Library Preparation Kits; Sequencing Kits; Target Enrichment Kits
• Companies Mentioned: F. Hoffmann-La Roche AG; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; BGI Genomics Co. Ltd.; Novogene Corporation; Oxford Nanopore Technologies Limited; Pacific Biosciences of California Inc.; MedGenome Labs Limited; Zymo Research Corporation; BaseClear B.V.; Psomagen Inc.; Karius Inc.; Microsynth AG; Macrogen Inc.; Norgen Biotek Corp.; Tiny Health Inc.; CosmosID Inc.; Kanvas Biosciences Inc.; Phase Genomics Inc.; Wobble Genomics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metagenomics In Healthcare Market Characteristics

3. Metagenomics In Healthcare Market Trends And Strategies

4. Metagenomics In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Metagenomics In Healthcare Growth Analysis And Strategic Analysis Framework

• 5.1. Global Metagenomics In Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Metagenomics In Healthcare Market Growth Rate Analysis
• 5.4. Global Metagenomics In Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Metagenomics In Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Metagenomics In Healthcare Total Addressable Market (TAM)

6. Metagenomics In Healthcare Market Segmentation

• 6.1. Global Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Extraction Kits
• Metagenomics Kits
• 6.2. Global Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray
• 6.3. Global Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Collection
• Deoxyribonucleic Acid Extraction
• Library Preparation
• Sequencing
• 6.4. Global Metagenomics In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Diagnosis
• Genomic Epidemiology
• Personalized Medicine
• Microbiome Analysis
• Drug Discovery
• 6.5. Global Metagenomics In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• 6.6. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Sample Extraction Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid Extraction Kits
• Ribonucleic Acid Extraction Kits
• Protein Extraction Kits
• 6.7. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Metagenomics Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Library Preparation Kits
• Sequencing Kits
• Target Enrichment Kits

7. Metagenomics In Healthcare Market Regional And Country Analysis

• 7.1. Global Metagenomics In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Metagenomics In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metagenomics In Healthcare Market

• 8.1. Asia-Pacific Metagenomics In Healthcare Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metagenomics In Healthcare Market

• 9.1. China Metagenomics In Healthcare Market Overview
• 9.2. China Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metagenomics In Healthcare Market

• 10.1. India Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metagenomics In Healthcare Market

• 11.1. Japan Metagenomics In Healthcare Market Overview
• 11.2. Japan Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metagenomics In Healthcare Market

• 12.1. Australia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metagenomics In Healthcare Market

• 13.1. Indonesia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metagenomics In Healthcare Market

• 14.1. South Korea Metagenomics In Healthcare Market Overview
• 14.2. South Korea Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metagenomics In Healthcare Market

• 15.1. Western Europe Metagenomics In Healthcare Market Overview
• 15.2. Western Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metagenomics In Healthcare Market

• 16.1. UK Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metagenomics In Healthcare Market

• 17.1. Germany Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metagenomics In Healthcare Market

• 18.1. France Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metagenomics In Healthcare Market

• 19.1. Italy Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metagenomics In Healthcare Market

• 20.1. Spain Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metagenomics In Healthcare Market

• 21.1. Eastern Europe Metagenomics In Healthcare Market Overview
• 21.2. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metagenomics In Healthcare Market

• 22.1. Russia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metagenomics In Healthcare Market

• 23.1. North America Metagenomics In Healthcare Market Overview
• 23.2. North America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metagenomics In Healthcare Market

• 24.1. USA Metagenomics In Healthcare Market Overview
• 24.2. USA Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metagenomics In Healthcare Market

• 25.1. Canada Metagenomics In Healthcare Market Overview
• 25.2. Canada Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metagenomics In Healthcare Market

• 26.1. South America Metagenomics In Healthcare Market Overview
• 26.2. South America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metagenomics In Healthcare Market

• 27.1. Brazil Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metagenomics In Healthcare Market

• 28.1. Middle East Metagenomics In Healthcare Market Overview
• 28.2. Middle East Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metagenomics In Healthcare Market

• 29.1. Africa Metagenomics In Healthcare Market Overview
• 29.2. Africa Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metagenomics In Healthcare Market Competitive Landscape And Company Profiles

• 30.1. Metagenomics In Healthcare Market Competitive Landscape
• 30.2. Metagenomics In Healthcare Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Metagenomics In Healthcare Market Other Major And Innovative Companies

• 31.1. QIAGEN N.V.
• 31.2. BGI Genomics Co. Ltd.
• 31.3. Novogene Corporation
• 31.4. Oxford Nanopore Technologies Limited
• 31.5. Pacific Biosciences of California Inc.
• 31.6. MedGenome Labs Limited
• 31.7. Zymo Research Corporation
• 31.8. BaseClear B.V.
• 31.9. Psomagen Inc.
• 31.10. Karius Inc.
• 31.11. Microsynth AG
• 31.12. Macrogen Inc.
• 31.13. Norgen Biotek Corp.
• 31.14. Tiny Health Inc.
• 31.15. CosmosID Inc.

32. Global Metagenomics In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metagenomics In Healthcare Market

34. Recent Developments In The Metagenomics In Healthcare Market

35. Metagenomics In Healthcare Market High Potential Countries, Segments and Strategies

• 35.1 Metagenomics In Healthcare Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Metagenomics In Healthcare Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Metagenomics In Healthcare Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer